Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Nov 7, 2022, after the close
10-Q filed Nov 8, 2022, 39 days after period end · 0001299130-22-000136
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $32.31M | $34.89M | $19.08M | $21.92M |
| Net Income | -$76.97M | $16.54M | -$23.71M | -$29.12M |
| EPS Diluted |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.34 |
| $0.08 |
| -$0.14 |
| -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
